📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance (2019)

First Author: Sale M

Attributed to: To define the molecular mechanisms that determine cellular and organismal longevity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-09438-w

PubMed Identifier: 31048689

Publication URI: http://europepmc.org/abstract/MED/31048689

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1

ISSN: 2041-1723